Abstract
Progesterone serum levels have been identified as a potential predictor for treatment effect in men with advanced prostate cancer, which is an androgen-driven disease. Although progesterone is the most abundant sex steroid in orchiectomized (ORX) male mice, the origins of progesterone in males are unclear.
To determine the origins of progesterone and androgens, we first determined the effect of ORX, adrenalectomy (ADX), or both (ORX + ADX) on progesterone levels in multiple male mouse tissues. As expected, intratissue androgen levels were mainly testicular derived. Interestingly, progesterone levels remained high after ORX and ORX + ADX with the highest levels in white adipose tissue and in the gastrointestinal tract. High progesterone levels were observed in mouse chow and exceptionally high progesterone levels were observed in food items such as dairy, eggs, and beef, all derived from female animals of reproductive age. To determine if orally ingested progesterone contributes to tissue levels of progesterone in males, we treated ORX + ADX and sham mice with isotope-labeled progesterone or vehicle by oral gavage. We observed a significant uptake of labeled progesterone in white adipose tissue and prostate, suggesting that dietary progesterone may contribute to tissue levels of progesterone. In conclusion, although adrenal-derived progesterone contributes to intratissue progesterone levels in males, nonadrenal progesterone sources also contribute. We propose that dietary progesterone is absorbed and contributes to intratissue progesterone levels in male mice. We speculate that food with high progesterone content could be a significant source of progesterone in males, possibly with consequences for men undergoing androgen deprivation therapy for prostate cancer.
Keywords: progesterone, androgens, adrenalectomy, gonadectomy, gas chromatography-tandem mass spectrometry, diet
Introduction
Progesterone levels in men have been identified as a potential predictor for prostate cancer treatment effect (1, 2). Serum progesterone levels increase in prostate cancer patients receiving the cytochrome P450 17α-hydroxylase/17,20-lyase (CYP17A1)-inhibitor abiraterone, which blocks local androgen production from adrenal precursors, and patients with higher progesterone serum levels after 3 months of abiraterone treatment had worse treatment outcomes. The oncogenic effect of progesterone in prostate cancer cell lines was partly androgen receptor dependent (2). Progesterone can locally, in tissues, be metabolized into the androgens testosterone and dihydrotestosterone (DHT) (3, 4) (Fig. 1). Accumulating evidence has shown that intratumoral production of DHT drives castration-resistant prostate cancer (5). Treatment with abiraterone hinders disease progression for some time, but resistance eventually occurs (6). In abiraterone-resistant prostate cancer cell lines, progesterone contributes to the activation of the androgen receptor (7).
Figure 1.
Schematic and simplified presentation of progesterone and androgens and their metabolic relationships.
Abbreviations: Cyp, cytochrome P450; DHP, dihydroprogesterone; DHT, dihydrotestosterone; HSD, hydroxysteroid dehydrogenase; OH prog, hydroxyprogesterone; StAR, steroidogenic acute regulatory protein.
The physiological roles of progesterone in males are still not fully known, but serum levels in men equal those in postmenopausal women (8, 9). Progesterone is the most abundant sex steroid in orchiectomized (ORX) male mice, and we have reported slightly higher progesterone levels in ORX mice compared to intact mice (10). Progesterone is generally described as being produced in both adrenals and gonads of men (8, 11). Yet, the relative importance of the gonads and adrenals for progesterone levels in males has, to the best of our knowledge, not previously been thoroughly investigated.
We have previously quantified high local levels of androgens, especially DHT, in the intestinal contents of mice of both sexes as well as in healthy men (12). In both mice and men, testicles are the main source of testosterone, the main circulating androgen that can locally be transformed into the more potent androgen DHT (Fig. 1). The human adrenal gland also produces androgen precursors such as dehydroepiandrosterone (13-15) and androstenedione, which can be converted to active sex steroids in peripheral tissues (16). In mice, adrenals produce other androgen precursors and contribute to intratumoral levels of DHT promoting the growth of prostate cancer xenografts in the absence of gonadal androgen production (5, 17). It has also been shown that castration-resistant prostate cancer utilizes alternative pathways for intratumoral synthesis of DHT via pathways that bypass testosterone entirely (18).
The primary aim of the present study was to determine the origins of progesterone in male mice; the secondary aim was to determine the origins of intestinal and local androgens. To this end, we have subjected male mice to either adrenalectomy (ADX), ORX, or both (ORX + ADX) and measured progesterone, testosterone, and DHT in serum, multiple peripheral tissues, and different parts of the gastrointestinal tract, comparing it to controls. As we found surprisingly high remaining levels of progesterone in tissues and intestinal contents after ORX + ADX, we evaluated hormone levels in mouse chow. Then, to functionally evaluate if the high progesterone levels found in the diet could contribute to the levels found in WAT of ORX + ADX mice, we administered stable isotope-labeled progesterone or vehicle by oral gavage and analyzed labeled progesterone uptake in tissues.
Methods
Animals and Surgeries
Male C57BL/6NRj mice (11 weeks old) were purchased from Janvier Labs (Le Genest St Isle, France) and allowed to acclimatize for at least 5 days before surgery. Mice were kept in individually ventilated cages in a standard animal facility with a 12-hour light/12-hour dark cycle with free access to chow pellets (RM3(E), Special Diets Services, Essex, UK) and tap water. After ADX the mice received 0.9% saline instead of water to maintain sodium balance.
Mice were randomly divided into 4 groups: intact (control, n = 10), ADX (n = 15), ORX (n = 10), and ORX + ADX (n = 12). The ORX + ADX group was adrenalectomized 3 weeks before sacrifice, and the remaining surgeries (all orchiectomies and adrenalectomies of the ADX group) were performed 2 weeks before sacrifice and tissue collection. Mice were individually housed starting 2 weeks before sacrifice in order to avoid fighting in the cages. In the control group, 3 individuals were accidentally cohoused, and they were excluded from analysis.
When isotope-labeled progesterone was used, mice were subjected to ORX and ADX or sham surgery 2 weeks before sacrifice. After 2 days of post-surgical recovery, they received daily by oral gavage labeled progesterone (Progesterone-2,3,4,20,21-13C5, Sigma-Aldrich, St. Louis MO, USA) 3000 ng/day (n = 5 for ORX + ADX, n = 7 for sham operated) or vehicle only (Phosal PG 50, Lipoid, Ludwigshafen, Germany; n = 6 for ORX + ADX, n = 7 for sham operated) until the end of the study. The mice in this study were cohoused within the groups for animal welfare reasons.
Surgeries were performed under isoflourane anesthesia. The mice received preoperative analgesia buprenorphine 0.05 to 0.1 mg/kg (Temgesic, Individor Europe, Dublin, Ireland) and either carprofen (Rimadyl, Zoetis, Helsinki, Finland) or meloxicam (Metacam, Boehringer Ingelheim, Copenhagen, Denmark) subcutaneously. Carprofen or meloxicam was also given for up to 3 days postoperatively. Mice in the main experiment were fasted for 3 hours prior to sacrifice to enable sampling of bile. Bile was withdrawn using a 1 mL insulin syringe before the dissection of the liver. At sacrifice, the absence of adrenal tissue in ADX mice was confirmed, and animals with suspected remnants of adrenal tissue were excluded from the analyses (1 from the ORX + ADX group, 4 from the ADX group, none from the oral progesterone experiment). Tissues, bile content, and content from different parts of the gastrointestinal tract (stomach, small intestine, and cecum) were snap frozen in liquid nitrogen and stored at −80°C until analysis. Blood was collected from the axillary vein and allowed to coagulate at room temperature for at least 30 minutes and then centrifuged to separate the serum, which was then frozen. As the gall bladder was not filled in all animals and due to sampling errors, a sufficient amount of bile for analysis (>10 μL) was only available from 25/39 animals. The experiments were conducted in accordance with all relevant legislation and approved by the Finnish National Animal Experiment Board (ethical permission no. 5239/04.10.07/2017) or the Ethical Committee for Animal Research in Gothenburg, Västra Götaland (ethical permission no. 5.8.18-11628/2019).
Tissues and serum from germ-free and conventionally raised 8-week-old C57BL/6NTac male mice (n = 10 per group) were purchased from Taconic (Germantown, NY, USA). These mice had free access to autoclaved NIH-31 M diet.
Sex Steroid Analysis
Sample Preparation
Frozen samples were thawed on ice. Samples from tissues, intestinal contents, and food were weighed and placed in 2 mL screw-top Eppendorf tubes with 450 µL PBS and homogenized by shaking with a 5 mm steel bead in a Tissuelyzer II (Qiagen, Hilden, Germany) for 5 minutes. Serum and bile samples were measured volumetrically by pipetting.
Mouse diets for steroid measurements were donated from colleagues and vendors. The diets included plant-based phytoestrogen-free diets, high-fat diets, purified diets, open-source diets, and custom diets with nonhormonal additives (Table 1). Samples of human foods were purchased at a local supermarket in Gothenburg, Sweden (Table 2).
Table 1.
Sex steroid levels in different mouse diets
| Vendor | Diet | Fata | Animal fata | Fat sourcesa | Progesterone | Testosterone | DHT |
|---|---|---|---|---|---|---|---|
| % | % | pg/g | pg/g | pg/g | |||
| Research Diets | D12492i | 34.8 | 31.6 | Lard, soybean oil | 17 702 (183) | 894 (23) | 42 (5) |
| Research Diets | D12492 | 34.8 | 31.6 | Lard, soybean oil | 13 440 (304) | 111 (14) | ND |
| Research Diets | D12451 | 23.6 | 20.6 | Lard, soybean oil | 9 072 (36) | 115 (22) | ND |
| Lantmännen | R34 Vitamin E aspirin | 4 | 0 | Soybean oil | 8 540 (1 402) | 520 (7) | 205 (15) |
| Plexxicon | PLX + drug | Unknown | Unknown | 7 709 (303) | 652 (9) | ND | |
| Lantmännen | R34 + betacarotene | 4 | 0 | Soybean oil | 7 654 (597) | 686 (25) | 830 (136) |
| Research Diets | D12450Bi | 4.3 | 1.9 | Soybean oil, lard | 7 262 (83) | 721 (29) | 37 (6) |
| Lantmännen | R34 aspirin | 4 | 0 | Soybean oil | 6 354 (618) | 744 (37) | 296 (15) |
| Envigo | 2914C Teklad Global | 4 | 0 | Soybean oil | 6 334 (268) | 793 (54) | 257 (20) |
| SAFE | U8959 version 0001 | 5 | ∼ 2 | Lard, colza oil, corn oil | 6 135 (34) | 127 (24) | ND |
| Envigo | 2916 Teklad Global batch A | 4 | 0 | Soybean oil | 5 791 (954) | 526 (26) | 343 (37) |
| Special Diet Services | RM3(E) batch B | 4.3 | 0 | Soybean oil | 5 374 (177) | 849 (39) | 308 (71) |
| Envigo | 2916 Teklad Global batch B | 4 | 0 | Soybean oil | 5 122 (419) | 636 (40) | 89 (18) |
| Lantmännen | R34 + vitamin E | 4 | 0 | Soybean oil | 4 642 (467) | 712 (59) | 405 (38) |
| SAFE | U8978 version 0022 | 7 | 0 | Soybean oil | 4 520 (27) | ND | ND |
| Plexxicon | PLX control | Unknown | Unknown | 4 067 (70) | 105 (13) | ND | |
| Research Diets | D12331 | 35.9 | 0 | Coconut oil, soybean oil | 3 916 (209) | 87 (11) | ND |
| SAFE | 150 | No added fat | 0 | 3 708 (964) | 310 (34) | ND | |
| SAFE | A04 | No added fat | 0 | 3 401 (627) | 454 (19) | ND | |
| Special Diet Services | RM3(E) batch A | 4.3 | 0 | Soybean oil | 2 878 (54) | 284 (17) | 547 (99) |
| Research Diets | D12328 | 4.8 | 0 | Soybean oil, coconut oil | 2 707 (85) | 54 (12) | ND |
| Lantmännen | R34 | 4 | 0 | Soybean oil | 2 319 (144) | 304 (10) | 214 (23) |
| Concentrations presented as mean (SEM) from at least triplicate samples | Mean | 6 302 (769) | 442 (63) | 166 (47) | |||
Abbreviations: DHT, dihydrotestosterone; ND, not detectable.
Information on fat content is taken from vendors or calculated/approximated from available documentation.
Table 2.
Sex steroid levels in different human food items
| Product | Progesterone | Testosterone | DHT |
|---|---|---|---|
| Butter | 192 453 (21 812) | ||
| Egg yolk | 150 401 (60 926) | 416 (74) | 39 (3) |
| Cream | 123 162 (1 282) | ||
| Egg white | 21 512 (600) | ||
| Ground beef | 13 876 (886) | ||
| Cow's milk | 6 362 (27) | ||
| Sunflower seeds | 421 (155) | ||
| Castor oil | 568 (32) | ||
| Pork fat | 256 (16) | ||
| Chickpeas | 201 (16) | ||
| Pasta | 172 (2) | ||
| Potatoes | |||
| Extra virgin olive oil | |||
| Chicken thigh fillet | |||
| Salmon fillet | |||
| Walnuts | |||
| Cod fillet |
Abbreviations: DHT, dihydrotestosterone.
Concentrations are measured in at least triplicate and presented as mean (SEM) pg/g. Empty cells indicate not detectable levels.
Deglucuronidation
We have previously developed and validated a gas chromatography tandem mass spectroscopy (GC-MS/MS) assay that measures androgens and progesterone with high specificity (10, 12, 19). To assess glucuronidated forms of androgens in bile and small intestine, we compared free levels of each hormone with and without enzymatic deglucuronidation as previously described (12). Briefly, samples were divided into 2 aliquots before homogenization, and 1 of the aliquots from each sample was deglucuronidated by adding 50 µL ß-glucuronidase (from E.coli K 12 in 50% glycerol solution; Roche, Basel, Switzerland), followed by brief vortexing and incubating at 37˚C with agitation for 60 minutes. Samples were then frozen at −80˚C until steroid extraction and analysis. The difference between total and free levels was calculated at each site and labeled glucuronidated (gluc).
Sex Steroid Extraction and Analysis
Steroids were extracted, derivatized, and measured as described previously (10, 12, 19). Briefly, after addition of isotope-labeled internal standards, steroids were extracted by liquid-liquid extraction with 1-chlorobutane, followed by solid phase extraction using Silica SPE columns (Hypersep Si 500 mg; Thermo Fisher Scientific, Waltham, MA, USA) that were washed with ethylacetate-pentane-heptane [10:45:45 (vol:vol)]. Next, the analytes were eluted to isooctane and the organic solvent evaporated. Finally, derivatization was performed in 2 steps: oximation with pentafluorobenzylhydroxylamine hydrochloride followed by esterification with pentafluorobenzoyl chloride. Progesterone, DHT, and testosteronewere separated by gas chromatography and detected simultaneously with negative chemical ionization by an Agilent 7000 triple quadrupole mass spectrometer (Agilent, Santa Clara, CA, USA) operating in multiple reaction monitoring mode with ammonia as reagent gas; mass transitions are reported in Supplementary Table 1 (20). Peaks were integrated using the MassHunter quantitative analysis workstation software from Agilent. Measured concentrations were corrected for amount of input material (wet mass of intestinal contents and tissues or volume of serum and bile). The method has been validated in serum, different types of tissues (lean, adipose tissue, and liver, which is a complex and metabolite-rich matrix), and intestinal contents (10, 12, 19, 21). A description of the validation experiments can be found in the supplementary materials (20). The lower limits of quantification (LLOQs) for the reported analytes were published previously and are summarized in Table 3. For the prostate, the sensitivity of the assay for progesterone was improved compared with our previous publication to an LLOQ of 19 pg/g. For the analysis of 13C5-progesterone, the mass units for multiple reaction monitoring were adjusted for the higher mass provided by the additional 13C atoms. In these measurements, no internal standard was used as the 13C3-progesterone normally used as internal standard was found to interfere with measurement of 13C5-progesterone. In vehicle-treated mice, a baseline reading of 13C5-progesterone was seen, reflecting the natural presence of carbon 13. To evaluate the presence of labeled progesterone, we performed 2 independent calculations: first, the uncorrected GC-MS/MS-area for 13C5-progesterone per input mass of tissue was determined. The area per input mass was normalized so that the mean value of the control group was 1 and the results were reported as arbitrary units (Fig. 2). In a second independent calculation, to estimate the concentration of labeled progesterone in relation to the levels of endogenous progesterone, the area for the labeled progesterone was divided by the area for the unlabeled progesterone in the same analysis as a replacement for an internal standard (Supplementary Fig. S1) (20).
Table 3.
Sensitivity of the gas chromatography-tandem mass spectroscopy assay in different matrices
| LLOQ (pg/g) | Progesterone | Testosterone | DHT |
|---|---|---|---|
| Muscle (lean tissue) | 75 | 20 | 8.0 |
| Liver | 75 | 40 | 4.0 |
| Adipose tissue | 75 | 40 | 4.0 |
| Intestinal contents | 40 | 20 | |
| Serum (pg/mL) | 74 | 8 | 2.5 |
Figure 2.
Uptake of orally administered labeled progesterone in tissues. Orchiectomized and adrenalectomized (ORX + ADX) or sham operated male C57Bl6/NRj mice were treated by oral gavage with either stable isotope-labeled progesterone (13C5-Prog; n = 5 for ORX + ADX, n = 7 for sham) or vehicle (n = 6 for ORX + ADX; n = 7 for sham) for 11 days. The area of the response from the gas chromatography/tandem mass spectroscopy was divided with the mass of input material, followed by normalization of all values to the mean for the vehicle group for that tissue. Bars represent the mean with error bars representing the standard error of the mean. Scatters represent individual values. Two-way ANOVA (treatment, surgery, and their interactions) for each tissue after log-transformation of the values.
Abbreviations: NS, not significant; Retro, retroperitoneal.
In mouse tissues and serum, values below the LLOQ were set to LLOQ/√2 in order not to overestimate undetectable hormone levels (22). To calculate the levels of glucuronidated steroids in small intestine and bile, the free level (concentration without glucuronidation) was subtracted from the total level (concentration after deglucuronidation) as described previously (12). One gram of tissue or intestinal contents was considered equivalent to 1 milliliter of serum or bile. In mouse chow and food, measurements below the lowest point of the standard curve or below the LLOQ in tissues were denoted as not detected.
Gene Expression Analysis
RNA was isolated from gonadal fat using TriZol reagent (Thermo Fisher Scientific) followed by RNeasy Mini Kit (Qiagen). The RNA was reverse transcribed into cDNA using High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). Real-time PCR analyses were performed using the StepOnePlus Real-Time PCR System (Applied Biosystems) and Taqman probes (Thermo Fisher Scientific), labeled with the reporter fluorescent dye FAM (Star: Mm00441558_m1, Cyp11a1: Mm00490735_m1, Hsd3b1: Mm00476184_g1, Hsd3b2: Mm00462683_g1, Hsd3b3: Mm001729523_m1, Hsd3b6: Mm00834440_m1). As an internal standard, predesigned primers and probe labeled with the reporter fluorescent dye VIC, specific for 18S ribosomal RNA (4310893E, Applied Biosystems), were included in the reactions. The gene expression was calculated using the ΔΔCT method with 18S as reference gene.
Statistics
Graph Pad Prism 9 (Graph Pad Software, San Diego, CA, USA) and Microsoft Excel 16 (Microsoft, Redmond, WA, USA) were used for statistics. Sex steroid levels were log transformed. The effect of ORX and ADX and their interaction factor was evaluated using two-way ANOVA. Comparison of 2 groups was done by Student's t-test. Comparison of the effect of treatment and surgeries in the labeled progesterone study was done using two-way ANOVA. The correlation analysis in the diet was performed using Pearson correlation.
Results
To determine the origins of progesterone and androgens in male mice, we first analyzed sex hormone levels in serum, liver, prostate, seminal vesicles, white adipose tissue (WAT; gonadal fat), kidney, testicles, adrenals, and the levator ani muscle (m. levator ani) as well as contents of the gastrointestinal tract (stomach, small intestine, cecum, and bile) with and without ORX and/or ADX.
Progesterone was detected in most tissues with substantial levels remaining after ORX and ADX (Fig. 2). In WAT, progesterone levels were higher than serum levels and progesterone levels in WAT after ORX + ADX were similar to those in intact mice (1630 pg/g ± 239 vs 1871 pg/g ± 124; mean ± SEM) (Fig. 3). In the adrenals, progesterone concentrations were substantially higher than in all other investigated tissues both with and without ORX, supporting the notion that progesterone may be secreted from the adrenals. Adrenalectomy did not significantly affect progesterone levels at most sites. In the gastrointestinal tract, progesterone levels started at around 800 pg/g in the stomach and decreased slightly to around 500 pg/g in small intestine and cecum with no effect from ORX or ADX (Fig. 3). Progesterone increased after ORX in the prostate and in the sex steroid-metabolizing/excreting organs, liver and kidney. No progesterone was detected in the bile (Fig. 3). As progesterone levels remained essentially unchanged in several parts of the body after ORX + ADX, another source of progesterone other than the gonads or adrenals must exist.
Figure 3.
Progesterone levels in tissues and gastrointestinal contents of male mice subjected to ADX and/or ORX. Male C57Bl6/NRj mice were subjected to ADX (n = 11), ORX (n = 10), or both (ADX + ORX, n = 11), and local progesterone levels were measured using gas chromatography/tandem mass spectroscopy 2 weeks after last surgery, compared to control mice (n = 7). All values represent free, unconjugated progesterone. Two-way ANOVA (ADX, ORX, and their interactions) for each tissue after log-transformation of the values. Bars represent the mean with error bars representing the standard error of the mean. Scatters represent individual values.
Abbreviations: ADX, adrenalectomy; Lev ani, levator ani muscle; ND, not detectable; NS, not significant; ORX, orchiectomy; sm int, small intestine; WAT, white adipose tissue.
Testosterone and DHT concentrations were undetectable or significantly reduced in most sites after ORX with or without ADX (Figs. 4 and 5). After ORX, testosterone was reduced in the peripheral tissues WAT, prostate, seminal vesicles, m. levator ani, and kidney to near or below the LLOQ (Fig. 4). The potent androgen DHT decreased after ORX to 1/50 to 1/200 in prostate, WAT, cecum, and m. levator ani, with levels after ORX close to or below the LLOQ in serum, liver, kidney, and bile (Fig. 5). All of the testosterone and DHT detected in the bile was glucuronidated, and the majority of the testosterone and DHT detected in the small intestine was glucuronidated (Supplementary Table 2) (20). In intact males, the concentration of free DHT in cecum was similar to the concentration of glucuronidated DHT detected in the bile and small intestine, indicating that the majority of DHT found in the intestine originated from the circulation and was excreted via the bile into the intestine. Interestingly, low but measurable concentrations of DHT were present in the prostate, m. levator ani, and WAT in mice lacking both testes and adrenals (Fig. 5). Thus, we did not detect any significant adrenal contribution to the levels of testosterone or DHT in serum or most tissues.
Figure 4.
Testosterone levels in tissues and gastrointestinal contents of male mice subjected to ADX and/or ORX. Male C57Bl6/NRj mice were subjected to ADX (n = 11), ORX (n = 10), or both (ADX + ORX, n = 11), and local testosterone levels were measured using gas chromatography/tandem mass spectroscopy 2 weeks after last surgery, compared to control mice (n = 7). The values in bile and small intestine represent glucuronidated testosterone (expressed as concentration testosterone); all other values represent free testosterone. Two-way ANOVA (ADX, OR,X and their interactions) for each tissue after log-transformation of the values. Bars represent the mean with error bars representing the standard error of the mean. Scatters represent individual values.
Abbreviations: ADX, adrenalectomy; Lev ani, levator ani muscle; ND, not detectable; NS, not significant; ORX, orchiectomy; sm int, small intestine; WAT, white adipose tissue.
Figure 5.
DHT levels in tissues and gastrointestinal contents of male mice subjected to adrenalectomy and/or orchiectomy. Male C57Bl6/NRj mice were subjected to adrenalectomy (ADX, n = 11) orchiectomy (ORX, n = 10) or both (ADX + ORX, n = 11) and local DHT levels were measured using gas chromatography/tandem mass spectroscopy two weeks after last surgery, compared to control mice (n = 7). The values in bile and small intestine represent glucuronidated DHT (expressed as concentration DHT), all other values represent free DHT. Two-way ANOVA (ADX, ORX and their interactions) for each tissue after log-transformation of the values. Bars represent the mean with error bars representing the standard error of the mean. Scatters represent individual values.
Abbreviations: ADX, adrenalectomy; DHT, dihydrotestosterone; Lev ani, levator ani muscle; ND, not detectable; NS, not significant; ORX, orchiectomy; sm int, small intestine; WAT, white adipose tissue.
As we found that progesterone levels were not majorly affected by ORX and/or ADX and progesterone levels were high in the gastrointestinal tract content, we hypothesized that the diet might be a source of intraintestinal progesterone. Analyses of the sex steroid content of the mouse chow used in the present study revealed high levels of progesterone (2878 ± 54 pg/g; 50x the serum levels in male mice) and rather low levels of androgens (Fig. 6; Table 1). To understand the generalizability of this finding, we also tested multiple other brands of mouse diets. All the sampled diets contained progesterone with concentrations between 2319 and 17702 pg per gram diet (mean 6302 pg/g). The level of progesterone correlated with the amount of animal-derived fat (lard) in the diets (Pearson correlation coefficient r = 0.79; P < .001), but significant amounts were also found in diets declared to contain only vegetable fats (Table 1). All diets contained added vitamins and minerals. The observation of high progesterone levels in different mouse diets was confirmed by an independent liquid chromatography mass spectrophotometric analytical method (9), yielding similar results as the GC-MS/MS method used in the present study (data not shown). In a selection of human food items, we found exceptionally high levels (>100-fold higher than male mouse tissue levels) of progesterone in dairy products, beef, and eggs, all derived from female animals at reproductive age (Table 2).
Figure 6.
Sex steroid contents in 22 different mouse chow samples measured using gas chromatography/tandem mass spectroscopy. Each sample was measured in at least triplicate, and the mean is given. The red diamond represents the measurement from the diet used in the current study.
Abbreviations: DHT, dihydrotestosterone; Prog, progesterone; T, testosterone.
To mechanistically evaluate if the dietary progesterone could be a source of progesterone in male mice, we administered stable isotope-labeled progesterone (13C5-progesterone) or vehicle by gavage to ORX + ADX and sham operated mice for 11 days. In WAT (both gonadal and retroperitoneal fat depots) and prostate, oral treatment with 13C5-progesterone substantially increased the presence of 13C5-progesterone in the tissues both when comparing weight-adjusted raw areas (Fig. 2) and when analyzing the areas in relation to the area for native progesterone (Supplementary Fig. 1) (20). The concentration of labeled progesterone in prostate and both types of WAT was around 10% of the concentration of native progesterone in treated ORX + ADX mice and around 1% in treated sham mice, suggesting that the contribution of orally ingested progesterone to intratissue levels of progesterone may be more pronounced after ADX (Supplementary Fig. 1) (20). As our data demonstrated that orally ingested progesterone contributes to tissue levels of progesterone in WAT, we evaluated if the gut microbiota may regulate progesterone uptake in male mice by comparing germ-free mice with conventionally raised mice. Serum levels of progesterone were not different (490 ± 256 pg/g vs 424 ± 176 pg/g; mean ± SEM), but in WAT, levels were higher (+ 142%; 11 155 ± 1 193 pg/g vs 4 607 ± 968 pg/g; P = .0003) in germ-free mice compared to conventionally raised mice.
Finally, to evaluate if local progesterone production in adipose tissue could be another source of progesterone in WAT of male mice, we analyzed gene expression of steroidogenic enzymes upstream of progesterone (StAR, Cyp11a1, Hsd3b1-3,5-6) (Fig. 1). StAR and Cyp11a1 were expressed in WAT but were not regulated by ADX or ORX. Hsd3b5 had a large variability in its expression while the other Hsd3b isoforms were not expressed (Table 4).
Table 4.
Expression of hormone-producing enzymes in gonadal fat
| Relative expression | ANOVA | ||||||
|---|---|---|---|---|---|---|---|
| Control | ADX | ORX | ADX + ORX | Surgery | Treatment | Interaction | |
| stAR | 1.94 (0.18) | 1.36 (0.18) | 2.14 (0.22) | 1.91 (0.28) | NS | NS | NS |
| Cyp11a1 | 2.10 (0.38) | 2.15 (0.48) | 2.41 (1.07) | 1.32 (0.20) | NS | NS | NS |
| HSD3b1 | ND | ND | ND | ND | |||
| HSD3b2 | ND | ND | ND | ND | |||
| HSD3b3 | ND | ND | ND | ND | |||
| HSD3b5 | 50.5 (39.7) | 85.6 (54.7) | 1.13 (0.74) | 1.41 (0.41) | NS | NS | NS |
| HSD3b6 | ND | ND | ND | ND | |||
Abbreviations: ADX, adrenalectomized; Cyp, cytochrome P450; HSD, hydroxysteroid dehydrogenase; ND, not detected; NS, not significant; ORX, orchiectomized; stAR, steroidogenic acute regulatory protein.
Arbitrary units, delta deltaCT method corrected for the expression of 18S presented as mean (SEM). Significances for each gene according to two-way ANOVA.
Discussion
As the origin of progesterone in males is unclear and progesterone levels have been shown to predict treatment success in advanced prostate cancer patients (2), we herein evaluated the origin of progesterone and androgens in male mice by analyzing serum and tissue hormone levels after ORX, ADX, or both. We found that even though progesterone was present in very high levels in the adrenals, progesterone levels remained unchanged in several tissues after ORX + ADX. We also demonstrated that progesterone can be taken up from the diet, in which it is present in high concentrations, suggesting that dietary progesterone is a possible source of intratissue levels of progesterone in male mice.
As expected, intratissue levels of androgens were mainly testis derived, but remaining levels of DHT in prostate and several other tissues after ORX + ADX suggest that some nongonadal, nonadrenal contribution to local androgen levels do exist. In contrast to the androgens, progesterone levels in serum, tissue, and intestinal contents showed surprisingly little dependence on adrenals or gonads in male mice. The high levels of progesterone in the stomach and the high concentrations of progesterone in all analyzed variants of mouse diets suggest that dietary progesterone contributes to the progesterone levels in the intestinal contents (Fig. 7). No progesterone was detected in the bile, demonstrating that there is no bile excretion of progesterone unlike for testosterone and DHT. Thus, we hypothesized that the progesterone levels found in serum and WAT could in part originate from the substantial intake of progesterone from food. This hypothesis was functionally tested, and we could clearly detect progesterone uptake into WAT and prostate when stable isotope-labeled progesterone was given orally to male mice. In ORX + ADX mice, the proportion of labeled to unlabeled progesterone was higher than in sham mice, suggesting that the contribution of orally ingested progesterone to intratissue levels of progesterone may be more pronounced in the absence of adrenals. Germ-free male mice had higher levels of progesterone in WAT compared to conventionally raised mice, suggesting that the overall effect of the gut microbiota may be to reduce the uptake of dietary progesterone.
Figure 7.
Visualization of sex steroid levels (light blue circles) in different body parts of intact male mice and proposed flow of the different hormones (yellow arrows) in the male mouse body. Darker blue circles represent conjugated (glucuronidated, gluc) hormones. Levels in endocrine organs (testicles and adrenals) are not shown. (A), testosterone is mainly produced in the testes and excreted into the intestine via bile; (B), DHT is locally produced for example in the prostate and dependent on testicular production of precursors; (C), progesterone originates from the adrenals and from intestinal uptake from food.
Abbreviations: DHT, dihydrotestosterone; m. lev ani, levator ani muscle.
Progesterone may contribute to growth of prostate cancer both as an androgen precursor and by nonandrogen dependent pathways (2). The androgen receptor-dependent effects of progesterone in prostate cancer cell lines have been reported to include both canonical and noncanonical androgen receptor signaling, involving activation of the transcription factor MYC (2). High MYC expression has been linked to worse prostate cancer progression and poorer treatment response in patients (23, 24). In addition, both progesterone receptor α and ß are expressed in prostate cancer tissue (25-27). High expression of progesterone receptor ß has been linked to clinical failure in prostate cancer patients (28, 29), but it is unclear if progesterone promotes prostate cancer growth via activation of progesterone receptor signaling. Thus, there are multiple possible mechanisms whereby progesterone could promote prostate cancer initiation or growth, and we speculate that these mechanisms may be affected by dietary progesterone in men.
In the present study, we observed very high progesterone levels in cow's milk and its derivatives as well as in eggs and some types of meat. This confirms previous findings (30, 31) and is in line with the high progesterone levels present in reproductive females. A possible uptake of dietary sex steroids in individuals with low endogenous sex steroids is supported by an altered urinary steroid profile after intake of cow´s milk in postmenopausal women (32) and short-term serum and urinary changes in progesterone after consumption of milk in prepubertal children (33). However, the possible uptake and bioavailability of dietary progesterone in men is unknown.
Prostate cancer and its relationship with different aspects of diet have been investigated in several studies but with equivocal results (34). In meta-analyses of prospective studies, prostate cancer risk has been linked to high intake of (certain) dairy products (35, 36), while other studies found no association of dairy intake and prostate cancer risk (37, 38). None of the studies analyzed circulating progesterone levels. In castrated mice, a low-carbohydrate diet could suppress the growth rate of prostate cancer xenografts and the intratumoral concentrations of DHT compared to a Western diet (39). The hormone levels of the 2 different diets used in that study were, however, not reported. We have, in the present study, shown that high and variable progesterone levels are present in mouse chow (and certain human food items) and that progesterone can be taken up in the intestine in mice. These findings suggest that dietary progesterone could be a factor to consider in future research on sex steroid-dependent diseases in men.
We and others have previously detected high levels of progesterone in the adrenals from different mouse strains (5, 10, 17). In some previous studies, progesterone levels in serum increased with ORX, similarly as seen in the present study, and decreased modestly with ADX (5, 17). Local progesterone levels in the prostate, liver, and kidney increased after ORX in the present study. We propose that the modest increase in progesterone levels observed after ORX (by us and others) may depend on the lower metabolism of progesterone as an androgen precursor when the testicles are removed. Another hypothesis is that ORX increases the adrenal weight and upregulates adrenal steroidogenic enzymes, thereby increasing adrenal progesterone production (5, 10). However, this does not seem to be the case in this study as the increase was observed even in ORX + ADX mice.
Gene expression analyses showed that there was no significant upregulation of progesterone-producing enzymes in WAT after ORX or ADX, indicating that increased local production in adipose tissue is not a major contributor to the remaining progesterone levels in ORX + ADX male mice.
In the present study, the systemic androgens testosterone and DHT originated mostly from the testicles. The presence of more glucuronidated testosterone and DHT in the bile and small intestine of gonadal intact mice than in ORX mice indicates that these hormones are secreted from the systemic circulation into the intestine, confirming the results of our previous study (12). Interestingly, low but measurable concentrations of DHT were present in the prostate, m. levator ani, and WAT in ORX + ADX mice in the present study. It is possible that the remaining high local progesterone levels in ORX + ADX mice might act as a precursor for the remaining DHT levels in these tissues. Indeed, expression of steroidogenic enzymes downstream of progesterone has been previously shown in both prostate (40, 41) and adipose tissue (42).
The present study has several strengths. We have used a highly sensitive and specific validated GC-MS/MS-method to determine sex steroid levels in multiple different matrices. This is the first study to analyze progesterone and androgens in different parts of the intestinal tract in ORX and ADX mice, as well as in mouse chow using the same GC-MS/MS methodology. We used stable isotope-labeled progesterone to mechanistically determine the possibility of uptake of dietary progesterone into tissues. Weaknesses of the current study include that it was not possible to directly quantify the labeled progesterone uptake, only relatively, due to interference between 13C3-progesterone normally used as internal standard and the dosed 13C5-progesterone. The measured hormone levels of highly vascularized tissues with low hormone levels may have been influenced by the hormone levels in the blood contained in the tissues at sacrifice. Further studies should evaluate the source of the progesterone found in mouse chow as well as the effect of dietary progesterone on systemic/local progesterone levels. Another area that merits further investigation is dietary progesterone's relevance as an androgen precursor or direct ligand in castration-resistant prostate cancer, especially in patients under androgen deprivation therapy.
In conclusion, although adrenal-derived progesterone is likely a major contributor to progesterone levels in males, nonadrenal progesterone sources also contribute. We propose that dietary progesterone can be absorbed and contribute to intratissue progesterone levels, of relevance especially after treatments blocking endogenous sex steroid synthesis. Also, the demonstrated presence of high levels of progesterone in many types of commonly used rodent chow could be an important factor to consider in future studies on sex steroid-dependent phenotypes. We finally propose that certain food items, derived from female animals of reproductive age, could be a substantial source of progesterone in males, possibly with consequences for men undergoing androgen deprivation therapy for prostate cancer.
Acknowledgments
The authors thank Anna Westerlund, Ulrika Björklund, Anna-Karin Norlén, and the personnel at Turku Center for Disease Modeling (www.tcdm.fi) for skillful assistance.
Contributor Information
Hannah Colldén, Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.
Malin Hagberg Thulin, Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.
Andreas Landin, Department of Drug Treatment, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg SE-413 45, Sweden.
Karin Horkeby, Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.
Marie Lagerquist, Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.
Jianyao Wu, Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.
Karin H Nilsson, Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.
Louise Grahnemo, Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.
Matti Poutanen, Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden; Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine and Turku Center for Disease Modeling, University of Turku, Turku FI-20014, Finland.
Henrik Ryberg, Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg SE-413 45, Sweden.
Liesbeth Vandenput, Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden; Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, VIC 3000, Australia.
Claes Ohlsson, Sahlgrenska Osteoporosis Centre at Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg SE-405 30, Sweden.
Funding
This study was supported by the Swedish Research Council [grant numbers 2018-02600 (L.V.) and 2020-01392 (C.O.)] and by grants from the Swedish state under the agreement between the Swedish government and the county councils [the ALF-agreement: ALFGBG-813251 (L.V.), ALFGBG-965235 (C.O.)], the IngaBritt och Arne Lundbergs Forskningsstiftelse (2017-0081), the Novo Nordisk Foundation (NNF19OC0055250), and the Knut and Alice Wallenberg Foundation (2020.0230).
Author Contributions
Designed research: H.C., L.V., M.P., C.O.; performed research: H.C., M.H.T., A.L., K.H., J.W., K.H.N., L.G.; supervised animal experiments: M.L.; analyzed data: H.C., M.H.T., A.L., H.R., M.P., L.V., C.O.; wrote the manuscript: H.C., L.V., C.O.; revised the manuscript: M.H.T., A.L., K.H., J.W., M.L., K.H.N., L.G., M.P., H.R., L.V., C.O. All authors approved the final version of the manuscript. H.C. and C.O. take responsibility for the integrity of the data analysis.
Disclosures
The authors have nothing to disclose.
Data Availability
Some or all datasets generated during the current study are not publicly available but are available from the corresponding author on reasonable request.
References
- 1. Mostaghel EA, Marck BT, Kolokythas O, et al. Circulating and intratumoral adrenal androgens correlate with response to abiraterone in men with castration-resistant prostate cancer. Clin Cancer Res. 2021;27(21):6001‐6011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Hou Z, Huang S, Mei Z, et al. Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer. Cell Rep Med. 2022;3(3):100561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Penning TM, Detlefsen AJ. Intracrinology-revisited and prostate cancer. J Steroid Biochem Mol Biol. 2020;196:105499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Deb S, Chin MY, Pham S, et al. Steroidogenesis in peripheral and transition zones of human prostate cancer tissue. Int J Mol Sci. 2021;22(2):487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Huhtaniemi R, Oksala R, Knuuttila M, et al. Adrenals contribute to growth of castration-resistant VCaP prostate cancer xenografts. Am J Pathol. 2018;188(12):2890‐2901. [DOI] [PubMed] [Google Scholar]
- 6. Desai K, McManus JM, Sharifi N. Hormonal therapy for prostate cancer. Endocr Rev. 2021;42(3):354‐373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Moll JM, Kumagai J, van Royen ME, et al. A bypass mechanism of abiraterone-resistant prostate cancer: accumulating CYP17A1 substrates activate androgen receptor signaling. Prostate. 2019;79(9):937‐948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Oettel M, Mukhopadhyay AK. Progesterone: the forgotten hormone in men? Aging Male. 2004;7(3):236‐257. [DOI] [PubMed] [Google Scholar]
- 9. Ohlsson C, Langenskiöld M, Smidfelt K, et al. Low progesterone and low estradiol levels associate with abdominal aortic aneurysms in men. J Clin Endocrinol Metab. 2022;107(4):e1413‐e1425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Colldén H, Nilsson ME, Norlén AK, et al. Comprehensive sex steroid profiling in multiple tissues reveals novel insights in sex steroid distribution in male mice. Endocrinology. 2022;163(3):bqac001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Kaore SN, Langade DK, Yadav VK, Sharma P, Thawani VR, Sharma R. Novel actions of progesterone: what we know today and what will be the scenario in the future? J Pharm Pharmacol. 2012;64(8):1040‐1062. [DOI] [PubMed] [Google Scholar]
- 12. Colldén H, Landin A, Wallenius V, et al. The gut microbiota is a major regulator of androgen metabolism in intestinal contents. Am J Physiol Endocrinol Metab. 2019;317(6):E1182‐E1192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. van Weerden WM, Bierings HG, van Steenbrugge GJ, de Jong FH, Schröder FH. Adrenal glands of mouse and rat do not synthesize androgens. Life Sci. 1992;50(12):857‐861. [DOI] [PubMed] [Google Scholar]
- 14. McNamara KM, Handelsman DJ, Simanainen U. The mouse as a model to investigate sex steroid metabolism in the normal and pathological prostate. J Steroid Biochem Mol Biol. 2012;131(3-5):107‐121. [DOI] [PubMed] [Google Scholar]
- 15. Laurent MR, Hammond GL, Blokland M, et al. Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis. Sci Rep. 2016;6(1):35539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Labrie F, Luu-The V, Bélanger A, et al. Is dehydroepiandrosterone a hormone? J Endocrinol. 2005;187(2):169‐196. [DOI] [PubMed] [Google Scholar]
- 17. Mostaghel EA, Zhang A, Hernandez S, et al. Contribution of adrenal glands to intratumor androgens and growth of castration-resistant prostate cancer. Clin Cancer Res. 2019;25(1):426‐439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Sharifi N. The 5α-androstanedione pathway to dihydrotestosterone in castration-resistant prostate cancer. J Investig Med. 2012;60(2):504‐507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Nilsson ME, Vandenput L, Tivesten A, et al. Measurement of a comprehensive sex steroid profile in rodent serum by high-sensitive gas chromatography-tandem mass spectrometry. Endocrinology. 2015;156(7):2492‐2502. [DOI] [PubMed] [Google Scholar]
- 20. Colldén H, Hagberg Thulin M, Landin A, et al. Supplemental materials for: Dietary progesterone contributes to intra-tissue levels of progesterone in male mice. doi: 10.5281/zenodo.8054450 [DOI] [PMC free article] [PubMed]
- 21. Colldén H, Nilsson ME, Norlén AK, et al. Dehydroepiandrosterone supplementation results in varying tissue-specific levels of dihydrotestosterone in male mice. Endocrinology. 2022;163(12):bqac163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Handelsman DJ, Ly LP. An accurate substitution method to minimize left censoring bias in serum steroid measurements. Endocrinology. 2019;160(10):2395‐2400. [DOI] [PubMed] [Google Scholar]
- 23. Qiu X, Boufaied N, Hallal T, et al. MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets. Nat Commun. 2022;13(1):2559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Sicotte H, Kalari KR, Qin S, et al. Molecular profile changes in patients with castrate-resistant prostate cancer pre- and post-abiraterone/prednisone treatment. Mol Cancer Res. 2022;20(12):1739‐1750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Bonkhoff H, Fixemer T, Hunsicker I, Remberger K. Progesterone receptor expression in human prostate cancer: correlation with tumor progression. Prostate. 2001;48(4):285‐291. [DOI] [PubMed] [Google Scholar]
- 26. Chen R, Yu Y, Dong X. Progesterone receptor in the prostate: a potential suppressor for benign prostatic hyperplasia and prostate cancer. J Steroid Biochem Mol Biol. 2017;166(6):91‐96. [DOI] [PubMed] [Google Scholar]
- 27. Spirina LV, Kovaleva IV, Usynin EA, Goorbunov AK, Kondakova IV. Progesterone receptor expression in the benign prostatic hyperplasia and prostate cancer tissues, relation with transcription, growth factors, hormone reception and components of the AKT/mTOR signaling pathway. Asian Pac J Cancer Prev. 2020;21(2):423‐429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Grindstad T, Richardsen E, Andersen S, et al. Progesterone receptors in prostate cancer: progesterone receptor B is the isoform associated with disease progression. Sci Rep. 2018;8(1):11358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Grindstad T, Andersen S, Al-Saad S, et al. High progesterone receptor expression in prostate cancer is associated with clinical failure. PLoS One. 2015;10(2):e0116691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Reksen O, Gröhn YT, Havrevoll Ø, Bolstad T, Waldmann A, Ropstad E. Relationships among milk progesterone, concentrate allocation, energy balance, milk yield and conception rate in Norwegian cattle. Anim Reprod Sci. 2002;73(3-4):169‐184. [DOI] [PubMed] [Google Scholar]
- 31. Okamoto Y, Nunome M, Kondo M, Kitayama I, Suzuki Y, Akiyama H. Quantification of progesterone in beef with marbling using liquid chromatography-tandem mass spectrometry with stable isotope-labelled standards. Food Addit Contam: Part A. 2021;38(3):409‐417. [DOI] [PubMed] [Google Scholar]
- 32. Michels KB, Binder N, Courant F, Franke AA, Osterhues A. Urinary excretion of sex steroid hormone metabolites after consumption of cow milk: a randomized crossover intervention trial. Am J Clin Nutr. 2019;109(2):402‐410. [DOI] [PubMed] [Google Scholar]
- 33. Wu J, Shi X, Zhang M, et al. Short-term serum and urinary changes in sex hormones of healthy pre-pubertal children after the consumption of commercially available whole milk powder: a randomized, two-level, controlled-intervention trial in China. Food Funct. 2022;13(20):10823‐10833. [DOI] [PubMed] [Google Scholar]
- 34. Matsushita M, Fujita K, Nonomura N. Influence of diet and nutrition on prostate cancer. Int J Mol Sci. 2020;21(4):1447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Aune D, Navarro Rosenblatt DA, Chan DS, et al. Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies. Am J Clin Nutr. 2015;101(1):87‐117. [DOI] [PubMed] [Google Scholar]
- 36. Gao X, LaValley MP, Tucker KL. Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst. 2005;97(23):1768‐1777. [DOI] [PubMed] [Google Scholar]
- 37. Preble I, Zhang Z, Kopp R, et al. Dairy product consumption and prostate cancer risk in the United States. Nutrients. 2019;11(7):1615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Huncharek M, Muscat J, Kupelnick B. Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer: a meta-analysis of 26,769 cases from 45 observational studies. Nutr Cancer. 2008;60(4):421‐441. [DOI] [PubMed] [Google Scholar]
- 39. Fokidis HB, Yieng Chin M, Ho VW, et al. A low carbohydrate, high protein diet suppresses intratumoral androgen synthesis and slows castration-resistant prostate tumor growth in mice. J Steroid Biochem Mol Biol. 2015;150:35‐45. [DOI] [PubMed] [Google Scholar]
- 40. Stanbrough M, Bubley GJ, Ross K, et al. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res. 2006;66(5):2815‐2825. [DOI] [PubMed] [Google Scholar]
- 41. Bennett NC, Hooper JD, Lambie D, et al. Evidence for steroidogenic potential in human prostate cell lines and tissues. Am J Pathol. 2012;181(3):1078‐1087. [DOI] [PubMed] [Google Scholar]
- 42. Li J, Papadopoulos V, Vihma V. Steroid biosynthesis in adipose tissue. Steroids. 2015;103:89‐104. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Some or all datasets generated during the current study are not publicly available but are available from the corresponding author on reasonable request.







